Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
Pre-Market
In 25 days
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a US-based biopharmaceutical company dedicated to researching and developing innovative medicines for chronic diseases. The company is advancing novel therapeutic approaches, particularly for diabetes, kidney diseases, and cardiovascular disorders, aiming to provide improved treatment options for patients globally.
All Dates
Earnings history data not available
Company Information
Name
Lexicon Pharmaceuticals
Country
🇺🇸
More Financial Information